JPWO2023127871A1 - - Google Patents
Info
- Publication number
- JPWO2023127871A1 JPWO2023127871A1 JP2023571048A JP2023571048A JPWO2023127871A1 JP WO2023127871 A1 JPWO2023127871 A1 JP WO2023127871A1 JP 2023571048 A JP2023571048 A JP 2023571048A JP 2023571048 A JP2023571048 A JP 2023571048A JP WO2023127871 A1 JPWO2023127871 A1 JP WO2023127871A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18821—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025024072A JP2025081483A (ja) | 2021-12-27 | 2025-02-18 | 温度感受性のマイナス鎖ｒｎａウイルスまたはウイルスベクターおよびそのｒｎａゲノム |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021213114 | 2021-12-27 | ||
| PCT/JP2022/048141 WO2023127871A1 (ja) | 2021-12-27 | 2022-12-27 | 温度感受性のマイナス鎖ｒｎａウイルスまたはウイルスベクターおよびそのｒｎａゲノム |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025024072A Division JP2025081483A (ja) | 2021-12-27 | 2025-02-18 | 温度感受性のマイナス鎖ｒｎａウイルスまたはウイルスベクターおよびそのｒｎａゲノム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023127871A1 true JPWO2023127871A1 (https=) | 2023-07-06 |
| JPWO2023127871A5 JPWO2023127871A5 (https=) | 2024-10-03 |
Family
ID=86998996
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571048A Pending JPWO2023127871A1 (https=) | 2021-12-27 | 2022-12-27 | |
| JP2025024072A Pending JP2025081483A (ja) | 2021-12-27 | 2025-02-18 | 温度感受性のマイナス鎖ｒｎａウイルスまたはウイルスベクターおよびそのｒｎａゲノム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025024072A Pending JP2025081483A (ja) | 2021-12-27 | 2025-02-18 | 温度感受性のマイナス鎖ｒｎａウイルスまたはウイルスベクターおよびそのｒｎａゲノム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250333760A1 (https=) |
| EP (1) | EP4458974A1 (https=) |
| JP (2) | JPWO2023127871A1 (https=) |
| CN (1) | CN118475700A (https=) |
| AU (1) | AU2022424476A1 (https=) |
| CA (1) | CA3243062A1 (https=) |
| WO (1) | WO2023127871A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2024195811A1 (https=) * | 2023-03-22 | 2024-09-26 | ||
| WO2025033445A1 (ja) | 2023-08-07 | 2025-02-13 | 株式会社Logomix | 遺伝子をコンディショナルに不活化させる方法、およびそのための細胞 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003025570A1 (fr) * | 2001-09-18 | 2003-03-27 | Dnavec Research Inc. | Methode permettant d'examiner un vecteur de virus a arn a brin negatif |
| WO2010008054A1 (ja) * | 2008-07-16 | 2010-01-21 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
| WO2012029770A1 (ja) * | 2010-08-30 | 2012-03-08 | ディナベック株式会社 | 多能性幹細胞を誘導するための組成物およびその使用 |
| US20140010791A1 (en) * | 2008-05-07 | 2014-01-09 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for regulating protein function in cells in vivo using synthetic small molecules |
| WO2017082174A1 (ja) * | 2015-11-13 | 2017-05-18 | 株式会社Ｉｄファーマ | 改良されたパラミクソウイルスベクター |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4206154B2 (ja) | 1997-11-13 | 2009-01-07 | 大日本住友製薬株式会社 | 変異型ｌｏｘＰ配列とその応用 |
| JP4787440B2 (ja) | 1999-09-30 | 2011-10-05 | 泉 斎藤 | 変異型ｆｒｔ配列を含有してなるｄｎａ |
| JP4999330B2 (ja) | 2004-01-22 | 2012-08-15 | 株式会社ディナベック研究所 | サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法 |
| JPWO2005071085A1 (ja) | 2004-01-22 | 2007-09-06 | 株式会社ディナベック研究所 | ウイルスベクターの製造方法 |
| JP2006180780A (ja) * | 2004-12-27 | 2006-07-13 | National Institute Of Advanced Industrial & Technology | 持続感染型センダイウイルスベクター |
| US8173792B2 (en) | 2007-02-09 | 2012-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Method for regulating protein function in cells using synthetic small molecules |
-
2022
- 2022-12-27 WO PCT/JP2022/048141 patent/WO2023127871A1/ja not_active Ceased
- 2022-12-27 JP JP2023571048A patent/JPWO2023127871A1/ja active Pending
- 2022-12-27 CN CN202280085608.1A patent/CN118475700A/zh active Pending
- 2022-12-27 US US18/724,497 patent/US20250333760A1/en active Pending
- 2022-12-27 AU AU2022424476A patent/AU2022424476A1/en active Pending
- 2022-12-27 EP EP22916094.0A patent/EP4458974A1/en active Pending
- 2022-12-27 CA CA3243062A patent/CA3243062A1/en active Pending
-
2025
- 2025-02-18 JP JP2025024072A patent/JP2025081483A/ja active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003025570A1 (fr) * | 2001-09-18 | 2003-03-27 | Dnavec Research Inc. | Methode permettant d'examiner un vecteur de virus a arn a brin negatif |
| US20140010791A1 (en) * | 2008-05-07 | 2014-01-09 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for regulating protein function in cells in vivo using synthetic small molecules |
| WO2010008054A1 (ja) * | 2008-07-16 | 2010-01-21 | ディナベック株式会社 | 染色体非組み込み型ウイルスベクターを用いてリプログラムされた細胞を製造する方法 |
| WO2012029770A1 (ja) * | 2010-08-30 | 2012-03-08 | ディナベック株式会社 | 多能性幹細胞を誘導するための組成物およびその使用 |
| WO2017082174A1 (ja) * | 2015-11-13 | 2017-05-18 | 株式会社Ｉｄファーマ | 改良されたパラミクソウイルスベクター |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4458974A1 (en) | 2024-11-06 |
| CN118475700A (zh) | 2024-08-09 |
| JP2025081483A (ja) | 2025-05-27 |
| AU2022424476A1 (en) | 2024-07-11 |
| US20250333760A1 (en) | 2025-10-30 |
| WO2023127871A1 (ja) | 2023-07-06 |
| CA3243062A1 (en) | 2025-04-16 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240925 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240925 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20240925 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241015 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241108 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20241119 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250218 |